Analyze Diet
Neurocritical care2013; 19(1); 111-115; doi: 10.1007/s12028-013-9822-5

Successful management of severe neuroinvasive eastern equine encephalitis.

Abstract: Eastern Equine Encephalitis (EEE) virus is an arbovirus that mostly causes asymptomatic infection in humans; however, some people can develop a neuroinvasive infection associated with a high mortality. Methods: We present a case of a patient with severe neuroinvasive EEE. Results: A 21-year-old man initially presented with headache, fever, and vomiting and was found to have a neutrophilic pleocytosis in his cerebrospinal fluid. He eventually was diagnosed with EEE, treated with high-dose methylprednisolone and intravenous immunoglobulin. His course in the NeuroIntensive Care Unit was complicated by cerebral edema and intracranial hypertension, requiring osmotherapy, pentobarbital and placement of an external ventricular device, and subclinical seizures, necessitating multiple anti-epileptic drugs Conclusions: A multifaceted approach including aggressive management of cerebral edema and ICP as well as treatment with immunomodulating agents and cessation of seizures may prevent brain herniation, secondary neurologic injury and death in patients with EEE. Effective management and treatment in our patient contributed to a dramatic recovery and ultimate good outcome.
Publication Date: 2013-06-05 PubMed ID: 23733173DOI: 10.1007/s12028-013-9822-5Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Case Reports
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article is about the successful treatment of a severe form of Eastern Equine Encephalitis (EEE), a virus that sometimes causes serious brain infections in humans, using an aggressive and varied approach.

Objective and Methods

  • The researchers studied the case of a 21-year-old male patient with severe neuroinvasive EEE, a typically asymptomatic virus in humans that can occasionally cause serious brain infections.
  • The patient first showed symptoms of headache, fever, and vomiting and was found to have neutrophilic pleocytosis in his cerebrospinal fluid, indicating inflammation.

Results

  • The patient was treated with high-dose methylprednisolone, a type of steroid, and intravenous immunoglobulin, antibodies given to boost the immune system.
  • However, the patient’s time in the NeuroIntensive Care Unit was complicated by cerebral edema (brain swelling) and intracranial hypertension (increased pressure inside the skull), leading to the need for osmotherapy (dehydration) and pentobarbital (sedatives).
  • The patient was also fitted with an external ventricular device to help drain cerebrospinal fluid and relieve pressure, and experienced subclinical seizures requiring the use of multiple anti-epileptic drugs.

Conclusions

  • The researchers concluded that a multifaceted approach including aggressive management of brain swelling and intracranial pressure, treatment with immunomodulating agents to boost the immune system, and cessation of seizures can prevent brain herniation, secondary neurological injury, and death in EEE patients.
  • This extensive treatment plan contributed to a remarkable recovery for the patient discussed in the study, leading to a positive prognosis.
  • This case study provides important insight on potential successful treatment approaches for severe neuroinvasive forms of EEE.

Cite This Article

APA
Wendell LC, Potter NS, Roth JL, Salloway SP, Thompson BB. (2013). Successful management of severe neuroinvasive eastern equine encephalitis. Neurocrit Care, 19(1), 111-115. https://doi.org/10.1007/s12028-013-9822-5

Publication

ISSN: 1556-0961
NlmUniqueID: 101156086
Country: United States
Language: English
Volume: 19
Issue: 1
Pages: 111-115

Researcher Affiliations

Wendell, Linda C
  • Departmentsof Neurology,Rhode Island Hospital/Warren Alpert School of Medicine at Brown University, 593 Eddy Street, APC 712, Providence, RI 02903, USA. linda_wendell@brown.edu
Potter, N Stevenson
    Roth, Julie L
      Salloway, Stephen P
        Thompson, Bradford B

          MeSH Terms

          • Anti-Bacterial Agents / therapeutic use
          • Anticonvulsants / therapeutic use
          • Antiviral Agents / therapeutic use
          • Brain Edema / drug therapy
          • Brain Edema / virology
          • Encephalomyelitis, Eastern Equine / drug therapy
          • Epilepsy, Generalized / drug therapy
          • Epilepsy, Generalized / virology
          • Humans
          • Immunologic Factors / therapeutic use
          • Intracranial Pressure
          • Male
          • Phenytoin / therapeutic use
          • Severity of Illness Index
          • Treatment Outcome
          • Young Adult

          References

          This article includes 11 references
          1. Neurocrit Care. 2012 Sep;17 Suppl 1:S66-72
            pubmed: 22961702
          2. Neurol Clin. 2008 May;26(2):427-68, viii
            pubmed: 18514821
          3. MMWR Morb Mortal Wkly Rep. 2012 Jul 13;61(27):510-4
            pubmed: 22785342
          4. N Engl J Med. 1986 Jan 16;314(3):144-9
            pubmed: 3001520
          5. Acta Anaesthesiol Scand. 2006 Jul;50(6):762-5
            pubmed: 16987375
          6. BMC Neurol. 2012 Sep 04;12:87
            pubmed: 22947340
          7. Clin Infect Dis. 2008 Aug 1;47(3):303-27
            pubmed: 18582201
          8. N Engl J Med. 1997 Jun 26;336(26):1867-74
            pubmed: 9197215
          9. J Neurosurg. 1988 Apr;68(4):585-8
            pubmed: 3351587
          10. MMWR Morb Mortal Wkly Rep. 2011 Aug 5;60(30):1009-13
            pubmed: 21814163
          11. Neurology. 2001 Feb 13;56(3):420-1
            pubmed: 11171919